- O
-
Laura Lucia Cogrossi – San Raffaele Scientific Institute ### 2076066###Speaker###PhD Student###San Raffaele Scientific Institute###
Speaker: – San Raffaele Scientific Institute
###
-
Jessica Encinas Mayoral (she/her/hers) – Fundación Investigación Biomédica Hospital 12 de Octubre ### 1442692###Speaker###PhD student###Fundación Investigación Biomédica Hospital 12 de Octubre###
Speaker: – Fundación Investigación Biomédica Hospital 12 de Octubre
### she/her/hers
-
Ross S. Firestone, MD/PhD (he/him/his) – Memorial Sloan Kettering Cancer Center, New York City NY, USA ### 2076051###Speaker###Fellow - Hematology / Oncology###Memorial Sloan Kettering Cancer Center, New York City NY, USA###
Speaker: – Memorial Sloan Kettering Cancer Center, New York City NY, USA
### he/him/his
-
Maximilian Merz, MD (he/him/his) – University of Leipzig ### 2131520###Speaker###Attending Physician###University of Leipzig###
Speaker: – University of Leipzig
### he/him/his
-
Simon J. Harrison, MBBS, MRCP(uk), FRCPath(uk), FRACP, PhD (he/him/his) – Peter MacCallum Cancer Centre ### 1395103###Speaker###Director, Centre of Excellence in Cellular Immunotherapy###Peter MacCallum Cancer Centre###
Speaker: – Peter MacCallum Cancer Centre
### he/him/his
-
Shuntaro Ikegawa, MD, PhD – Dana-Farber Cancer Institute ### 2076071###Speaker###Research fellow###Dana-Farber Cancer Institute###
Speaker: – Dana-Farber Cancer Institute
###
-
Hui Liu, LH – Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, China ### 1443969###Speaker###Professor###Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, China###
Speaker: – Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, China
###
-
Jieyun Xia, MD – The Affiliated Hospital of Xuzhou Medical University ### 2076072###Speaker###doctor###The Affiliated Hospital of Xuzhou Medical University###
Speaker: – The Affiliated Hospital of Xuzhou Medical University
###
-
Aintzane Zabaleta, PhD (she/her/hers) – CIMA (Pamplona) ### 2081759###Speaker###Research assistant###CIMA (Pamplona)###
Speaker: – CIMA (Pamplona)
### she/her/hers
-
Thomas Lund, MD, PhD (he/him/his) – Department of Hematology Odense University Hospital ### 1442963###Speaker###Associated Professor###Department of Hematology Odense University Hospital###
Speaker: – Department of Hematology Odense University Hospital
### he/him/his
-
Luis-Esteban Tamariz-Amador, MD – Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), IdiSNA ### 2076070###Speaker###MD###Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), IdiSNA###
Speaker: – Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), IdiSNA
###
-
Camila Guerrero – Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBER-ONC number CB16/12/00369 ### 1441952###Speaker###PhD Student###Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBER-ONC number CB16/12/00369###
Speaker: – Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), CIBER-ONC number CB16/12/00369
###
-
Ioannis V Kostopoulos, n/a – Section of Animal and Human Physiology, Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Athens, Greece ### 2076059###Speaker###Post doctoral research fellow###Section of Animal and Human Physiology, Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Athens, Greece###
Speaker: – Section of Animal and Human Physiology, Department of Biology, School of Sciences, National and Kapodistrian University of Athens, Athens, Greece
###
-
Panagiotis Malandrakis, MD (he/him/his) – Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece ### 1442827###Speaker###Scientific associate###Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece###
Speaker: – Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
### he/him/his
-
Frits van Rhee, MD PHD (he/him/his) – Myeloma Center, University of Arkansas of Medicine ### 1954268###Speaker###Professor of Medicine###Myeloma Center, University of Arkansas of Medicine###
Speaker: – Myeloma Center, University of Arkansas of Medicine
### he/him/his
-
Linda B. Baughn, PhD (she/her/hers) – Mayo Clinic, Rochester, MN, US ### 2076266###Speaker###Co-director, Cytogenetics Laboratory/Consultant###Mayo Clinic, Rochester, MN, US###
Speaker: – Mayo Clinic, Rochester, MN, US
### she/her/hers
-
Anthony Cirrincione, PhD – Myeloma Service, Sylvester Comprehensive Cancer Center, University of Miami ### 2076061###Speaker###Postdoctoral Associate###Myeloma Service, Sylvester Comprehensive Cancer Center, University of Miami###
Speaker: – Myeloma Service, Sylvester Comprehensive Cancer Center, University of Miami
###
-
Jian Cui – Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College ### 1719009###Speaker###postgraduate###Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College###
Speaker: – Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College
###
-
Kylee Maclachlan, MBChB, PhD – Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City NY, USA ### 1443581###Speaker###Assistant Attending Physician###Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City NY, USA###
Speaker: – Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City NY, USA
###
-
Alejandro Medina-Herrera, PhD – Departamento de Hematología, Hospital Universitario de Salamanca, (HUSA/IBSAL), Centro de Investigación del Cáncer-IBMCC (CSIC/USAL), CIBERONC ### 2076068###Speaker###Postdoctoral researcher###Departamento de Hematología, Hospital Universitario de Salamanca, (HUSA/IBSAL), Centro de Investigación del Cáncer-IBMCC (CSIC/USAL), CIBERONC###
Speaker: – Departamento de Hematología, Hospital Universitario de Salamanca, (HUSA/IBSAL), Centro de Investigación del Cáncer-IBMCC (CSIC/USAL), CIBERONC
###
-
Afsaneh Panahi, MSc – BC Cancer Research Centre/ University of British Columbia ### 2076074###Speaker###PhD candidate###BC Cancer Research Centre/ University of British Columbia###
Speaker: – BC Cancer Research Centre/ University of British Columbia
###
-
Andrea Poletti, PhD – IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli” - Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy ### 1441986###Speaker###Bioinformatician###IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli” - Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy###
Speaker: – IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli” - Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy
###
-
Alexandra M. Poos, PhD (she/her/hers) – Multiple Myeloma Section, Department of Medicine V, University Hospital Heidelberg ### 1442081###Speaker###PostDoc###Multiple Myeloma Section, Department of Medicine V, University Hospital Heidelberg###
Speaker: – Multiple Myeloma Section, Department of Medicine V, University Hospital Heidelberg
### she/her/hers
-
Leo Rasche, MD – Department of Internal Medicine II, University Hospital, 97080 Würzburg, Germany ### 1442365###Speaker###associate professor###Department of Internal Medicine II, University Hospital, 97080 Würzburg, Germany###
Speaker: – Department of Internal Medicine II, University Hospital, 97080 Würzburg, Germany
###
-
Rodger E. Tiedemann, MD, PhD (he/him/his) – Princess Margaret Cancer Centre ### 1395134###Speaker###Senior Scientist, Hematologist###Princess Margaret Cancer Centre###
Speaker: – Princess Margaret Cancer Centre
### he/him/his
-
Jian Cui – Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College ### 1719009###Speaker###postgraduate###Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College###
Speaker: – Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College
###
-
Parvathi Sudha, MS (she/her/hers) – Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA ### 2076063###Speaker###Research Associate###Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA###
Speaker: – Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA
### she/her/hers
-
Takahiro Kamiya, MD (he/him/his) – Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, Japan / Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan ### 2076050###Speaker###Graduate student###Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, Japan / Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan###
Speaker: – Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, Japan / Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
### he/him/his
-
Jonathan L. Kaufman, MD – Winship Cancer Institute of Emory University ### 1395159###Speaker###Professor of Hematology and Medical Oncology###Winship Cancer Institute of Emory University###
Speaker: – Winship Cancer Institute of Emory University
###
-
Hao Mu, Principle Investigation (she/her/hers) – State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China. ### 1442108###Speaker###Professor###State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.###
Speaker: – State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
### she/her/hers
-
Charan T R Vegivinti, MD (he/him/his) – Jacobi Medical Center / Albert Einstein College of Medicine ### 2076065###Speaker###Internal Medicine Resident###Jacobi Medical Center / Albert Einstein College of Medicine###
Speaker: – Jacobi Medical Center / Albert Einstein College of Medicine
### he/him/his
-
Brian A. Walker, PhD (he/him/his) – Indiana University ### 1395036###Speaker###Professor###Indiana University###
Speaker: – Indiana University
### he/him/his
-
Wen Zhou, PhD – Cancer Research Institute, Xiangya School of Medicine, Central South University ### 2076970###Speaker###Xiangya Road110# Changsha, Hunan Province, China###Cancer Research Institute, Xiangya School of Medicine, Central South University###
Speaker: – Cancer Research Institute, Xiangya School of Medicine, Central South University
###
-
Eyal Lebel, MD – Hadassah medical center ### 2076057###Speaker###Senior Physician and researcher###Hadassah medical center###
Speaker: – Hadassah medical center
###
-
Elizabeth D. Lightbody, PhD – Dana-Farber Cancer Institute ### 2076073###Speaker###Instructor in Medicine###Dana-Farber Cancer Institute###
Speaker: – Dana-Farber Cancer Institute
###
-
wei tan, Ph.D – The University of Texas MD Anderson Cancer Center ### 2076054###Speaker###Research Scientist###The University of Texas MD Anderson Cancer Center###
Speaker: – The University of Texas MD Anderson Cancer Center
###
-
Annika Werly – Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany ### 2076067###Speaker###Doctoral student###Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany###
Speaker: – Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
###
-
Jens Hillengass, MD, PhD – Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA ### 1409085###Speaker###Professor of Oncology and Internal Medicine###Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA###
Speaker: – Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
###
-
Hira Mian, MD, MSc, FRCPC – McMaster University, Hamilton, Ontario, Canada ### 1719006###Speaker###Assistant Professor###McMaster University, Hamilton, Ontario, Canada###
Speaker: – McMaster University, Hamilton, Ontario, Canada
###
-
Clark DuMontier, MD, MPH (he/him/his) – VA Boston Healthcare System and Brigham and Women's Hospital/Harvard Medical School ### 2076053###Speaker###Geriatrician, Assistant Professor###VA Boston Healthcare System and Brigham and Women's Hospital/Harvard Medical School###
Speaker: – VA Boston Healthcare System and Brigham and Women's Hospital/Harvard Medical School
### he/him/his
-
Darrell White, MD (he/him/his) – Dalhousie University and Queen Elizabeth II Health Sciences Centre ### 1443022###Speaker###Hematologist, Senior Associate Dean###Dalhousie University and Queen Elizabeth II Health Sciences Centre###
Speaker: – Dalhousie University and Queen Elizabeth II Health Sciences Centre
### he/him/his
-
Samer Al Hadidi, MD,MS,FACP – the University of Arkansas for Medical Sciences ### 1719063###Speaker###Assistant Professor###the University of Arkansas for Medical Sciences###
Speaker: – the University of Arkansas for Medical Sciences
###
-
Lisa B. Leypoldt, MD (she/her/hers) – University Medical Center Hamburg-Eppendorf, Germany / Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Medicine, Harvard Medical School, Boston, MA, USA. Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. Department of Hematology, Oncology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany ### 2076052###Speaker###Clinician Scientiest/ Research Fellow###University Medical Center Hamburg-Eppendorf, Germany / Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Medicine, Harvard Medical School, Boston, MA, USA. Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. Department of Hematology, Oncology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany###
Speaker: – University Medical Center Hamburg-Eppendorf, Germany / Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Department of Medicine, Harvard Medical School, Boston, MA, USA. Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. Department of Hematology, Oncology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
### she/her/hers
-
Meral Beksac, MD (she/her/hers) – Ankara University ### 1443293###Speaker###Professor of Hematology###Ankara University###
Speaker: – Ankara University
### she/her/hers
-
Carlos Fernandez de Larrea, MD, PhD – Hospital Clínic de Barcelona ### 1949895###Speaker###Consultant, Amyloidosis and Myeloma Unit, Department of Hematology###Hospital Clínic de Barcelona###
Speaker: – Hospital Clínic de Barcelona
###
-
Jiye Liu, PhD (he/him/his) – Dana-Farber Cancer Institute ### 1442056###Speaker###Instructor###Dana-Farber Cancer Institute###
Speaker: – Dana-Farber Cancer Institute
### he/him/his
-
Salomon Manier, MD, PhD – Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France ### 1395123###Speaker###Professor of Medicine###Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France###
Speaker: – Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France
###
-
Philippe Moreau, MD – University Hospital Hôtel-Dieu, Nantes, France ### 1395078###Speaker###Head of Hematology###University Hospital Hôtel-Dieu, Nantes, France###
Speaker: – University Hospital Hôtel-Dieu, Nantes, France
###
-
Albert Oriol, PhD (he/him/his) – Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain ### 1441780###Speaker###Head of the Clinical Research Unit###Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain###
Speaker: – Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain
### he/him/his
-
Niels van de Donk, MD PhD (he/him/his) – Amsterdam UMC ### 1949889###Speaker###professor###Amsterdam UMC###
Speaker: – Amsterdam UMC
### he/him/his
-
Maria-Victoria Mateos, PhD (she/her/hers) – University Hospital of Salamanca ### 1949876###Speaker###Head of Unit###University Hospital of Salamanca###
Speaker: – University Hospital of Salamanca
### she/her/hers
-
Noemi Puig, MD, PhD – Hospital Universitario de Salamanca, Instituto de investigación biomédica de Salamanca (IBSAL) ### 1395124###Speaker###Hematologist###Hospital Universitario de Salamanca, Instituto de investigación biomédica de Salamanca (IBSAL)###
Speaker: – Hospital Universitario de Salamanca, Instituto de investigación biomédica de Salamanca (IBSAL)
###
-
Cyrille Touzeau, MD, PhD – CHU Nantes ### 1395058###Speaker###Hematologist###CHU Nantes###
Speaker: – CHU Nantes
###
-
Shonali Midha, MD – Dana Farber Cancer Institute ### 2076281###Speaker###Physician###Dana Farber Cancer Institute###
Speaker: – Dana Farber Cancer Institute
###
-
Xavier P. Leleu, MD, PhD (he/him/his) – Hospital La Mileterie, Poitiers, France ### 1395160###Speaker###Head of Myeloma Clinic and Head of Department of Haematology###Hospital La Mileterie, Poitiers, France###
Speaker: – Hospital La Mileterie, Poitiers, France
### he/him/his
-
Monica Morris, MSc, RN – Myeloma UK ### 1408999###Co-Chair###Clinical Practice Services ###Myeloma UK###
Co-Chair: – Myeloma UK
### @@@ Ioanna Tsatsou ### 1996608###Co-Chair#########Co-Chair:
###
-
Evangelos Terpos, MD, PhD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece ### 1395152###Speaker###Professor###Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece###
Speaker: – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece
### he/him/his
-
Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School ### 1395035###Chair###Kraft Family Chair, Director of Basic and Correlative Science, Professor of Medicine, Harvard Medical School ###Dana-Farber Cancer Institute, Harvard Medical School###
Chair: – Dana-Farber Cancer Institute, Harvard Medical School
### @@@ Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA ### 1395145###Co-Chair###Professor of Medicine, Director of the Center for Blood Cancers Director of the Clinical Myeloma Pro###Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA###Co-Chair: – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
### she/her/hers
